Patrick Mauro Investment Advisor’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.97M Sell
48,960
-5,281
-10% -$308K 1.49% 23
2025
Q4
$2.93M Sell
54,241
-1,884
-3% -$90.6K 1.53% 23
2025
Q3
$2.53M Buy
+56,125
New +$2.62M 1.33% 28
2024
Q3
Sell
-12,051
Closed -$500K 44
2024
Q2
$500K Sell
12,051
-15,016
-55% -$672K 0.29% 40
2024
Q1
$1.47M Buy
27,067
+19,007
+236% +$968K 0.83% 31
2023
Q4
$414K Sell
8,060
-22,050
-73% -$1.16M 0.25% 38
2023
Q3
$1.75M Buy
30,110
+1,074
+4% +$65.8K 1.13% 29
2023
Q2
$1.86M Buy
29,036
+22,888
+372% +$1.53M 1.14% 29
2023
Q1
$426K Sell
6,148
-338
-5% -$23.8K 0.27% 37
2022
Q4
$467K Sell
6,486
-1,547
-19% -$117K 0.3% 39
2022
Q3
$571K Buy
+8,033
New +$583K 0.41% 39

Other funds holding BMY

Patrick Mauro Investment Advisor's BMY Position: Q1 2026 in Review

Patrick Mauro Investment Advisor reduced its Bristol-Myers Squibb (BMY) stake by 9.7% in Q1 2026, selling an estimated $308K and leaving 48,960 shares worth $2.97M. The position accounts for 1.49% of the portfolio, ranked #23.

Patrick Mauro Investment Advisor first reported a position in BMY in Q3 2022 and has held it in 11 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Patrick Mauro Investment Advisor held 48,960 shares of Bristol-Myers Squibb worth $2.97M as of Q1 2026.
  • Patrick Mauro Investment Advisor sold 5,281 Bristol-Myers Squibb shares in Q1 2026, an estimated $308K.
  • Bristol-Myers Squibb made up 1.49% of Patrick Mauro Investment Advisor's portfolio in Q1 2026, its #23 holding.
  • Patrick Mauro Investment Advisor first reported a position in Bristol-Myers Squibb in Q3 2022 and has held it in 11 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Patrick Mauro Investment Advisor's 13F filing for Q1 2026, filed 6 May 2026.